Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maura Brioschi

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
International Journal of Cardiology|August 28, 2015
Plasma immature form of surfactant protein type B correlates with prognosis in patients with chronic heart failure. A pilot single-center prospective studyDamiano Magrì, Cristina Banfi, Antonello Maruotti, et al.
Biomolecules|April 30, 2021
Immature Circulating SP-B, Bound to HDL, Represents an Early Sign of Smoke-Induced Pathophysiological AlterationsCristina Banfi, Maura Brioschi, Massimo Mapelli, et al.
Antioxidants (Basel, Switzerland)|October 23, 2021
Erratum: Altomare et al. In-Depth AGE and ALE Profiling of Human Albumin in Heart Failure: Ex Vivo Studies. <i>Antioxidants</i> 2021, <i>10</i>, 358Alessandra Altomare, Giovanna Baron, Marta Balbinot, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 11, 2004
Anti-inflammatory effects of AT1 receptor blockade provide end-organ protection in stroke-prone rats independently from blood pressure fallLuigi Sironi, Paolo Gelosa, Uliano Guerrini, et al.
Biomedicines|May 16, 2023
Impact of Sacubitril/Valsartan on Circulating microRNA in Patients with Heart FailureMaura Brioschi, Yuri D'Alessandra, Massimo Mapelli, et al.
Antioxidants (Basel, Switzerland)|May 2, 2020
<i>N</i>-Acetyl-Cysteine Regenerates Albumin Cys34 by a Thiol-Disulfide Breaking Mechanism: An Explanation of Its Extracellular Antioxidant ActivityAlessandra Altomare, Giovanna Baron, Maura Brioschi, et al.
Diabetes Research and Clinical Practice|May 11, 2025
Effects of low-dose rivaroxaban combined with low-dose aspirin versus low-dose aspirin alone on in vivo platelet activation, endothelial function and inflammation in type 2 diabetes patients with stable atherosclerotic disease: the RivAsa randomized, crossover studyAlessandro Rizzi, Giovanna Petrucci, Monica Sacco, et al.
The Journal of Biological Chemistry|October 15, 2009
An integrated approach for experimental target identification of hypoxia-induced miR-210Pasquale Fasanaro, Simona Greco, Maria Lorenzi, et al.
Circulation. Heart Failure|October 8, 2009
Circulating plasma surfactant protein type B as biological marker of alveolar-capillary barrier damage in chronic heart failureDamiano Magrì, Maura Brioschi, Cristina Banfi, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 25, 2010
Terutroban, a thromboxane/prostaglandin endoperoxide receptor antagonist, increases survival in stroke-prone rats by preventing systemic inflammation and endothelial dysfunction: comparison with aspirin and rosuvastatinPaolo Gelosa, Rossana Ballerio, Cristina Banfi, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
International Journal of Cardiology|August 28, 2015
Plasma immature form of surfactant protein type B correlates with prognosis in patients with chronic heart failure. A pilot single-center prospective studyDamiano Magrì, Cristina Banfi, Antonello Maruotti, et al.
Biomolecules|April 30, 2021
Immature Circulating SP-B, Bound to HDL, Represents an Early Sign of Smoke-Induced Pathophysiological AlterationsCristina Banfi, Maura Brioschi, Massimo Mapelli, et al.
Antioxidants (Basel, Switzerland)|October 23, 2021
Erratum: Altomare et al. In-Depth AGE and ALE Profiling of Human Albumin in Heart Failure: Ex Vivo Studies. <i>Antioxidants</i> 2021, <i>10</i>, 358Alessandra Altomare, Giovanna Baron, Marta Balbinot, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 11, 2004
Anti-inflammatory effects of AT1 receptor blockade provide end-organ protection in stroke-prone rats independently from blood pressure fallLuigi Sironi, Paolo Gelosa, Uliano Guerrini, et al.
Biomedicines|May 16, 2023
Impact of Sacubitril/Valsartan on Circulating microRNA in Patients with Heart FailureMaura Brioschi, Yuri D'Alessandra, Massimo Mapelli, et al.
Antioxidants (Basel, Switzerland)|May 2, 2020
<i>N</i>-Acetyl-Cysteine Regenerates Albumin Cys34 by a Thiol-Disulfide Breaking Mechanism: An Explanation of Its Extracellular Antioxidant ActivityAlessandra Altomare, Giovanna Baron, Maura Brioschi, et al.
Diabetes Research and Clinical Practice|May 11, 2025
Effects of low-dose rivaroxaban combined with low-dose aspirin versus low-dose aspirin alone on in vivo platelet activation, endothelial function and inflammation in type 2 diabetes patients with stable atherosclerotic disease: the RivAsa randomized, crossover studyAlessandro Rizzi, Giovanna Petrucci, Monica Sacco, et al.
The Journal of Biological Chemistry|October 15, 2009
An integrated approach for experimental target identification of hypoxia-induced miR-210Pasquale Fasanaro, Simona Greco, Maria Lorenzi, et al.
Circulation. Heart Failure|October 8, 2009
Circulating plasma surfactant protein type B as biological marker of alveolar-capillary barrier damage in chronic heart failureDamiano Magrì, Maura Brioschi, Cristina Banfi, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 25, 2010
Terutroban, a thromboxane/prostaglandin endoperoxide receptor antagonist, increases survival in stroke-prone rats by preventing systemic inflammation and endothelial dysfunction: comparison with aspirin and rosuvastatinPaolo Gelosa, Rossana Ballerio, Cristina Banfi, et al.
Pageof 7